Trials / Withdrawn
WithdrawnNCT02181205
Sphenopalatine Ganglion Block for Post-Dural Puncture Headache
Sphenopalatine Ganglion Block for Treatment of Postdural Puncture Headache: A Prospective Randomized Double Blind Placebo Controlled Study
- Status
- Withdrawn
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- Wake Forest University Health Sciences · Academic / Other
- Sex
- Female
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Not accepted
Summary
The investigators are attempting to determine a less invasive method of treatment for postdural puncture headaches that can occur after regional anesthesia. The investigators will be evaluating the relief of headache with those subjects receiving treatment with a sphenopalatine ganglion block with bupivacaine versus placebo, evaluating the incidence of epidural blood patch, pain score of headache at 1 hour, then 24, 48, and 72 hours lower with post study treatment versus placebo, and potential side effects of those patients receiving study therapy as well as epidural blood patch.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | bupivacaine | |
| DRUG | placebo |
Timeline
- Start date
- 2014-11-01
- Primary completion
- 2016-12-31
- Completion
- 2016-12-31
- First posted
- 2014-07-03
- Last updated
- 2017-11-08
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02181205. Inclusion in this directory is not an endorsement.